ES2177584T3 - Composicion de prostaglandinas transdermica. - Google Patents

Composicion de prostaglandinas transdermica.

Info

Publication number
ES2177584T3
ES2177584T3 ES94931344T ES94931344T ES2177584T3 ES 2177584 T3 ES2177584 T3 ES 2177584T3 ES 94931344 T ES94931344 T ES 94931344T ES 94931344 T ES94931344 T ES 94931344T ES 2177584 T3 ES2177584 T3 ES 2177584T3
Authority
ES
Spain
Prior art keywords
transdermica
prostaglandinas
composition
polyisobutilene
transdermic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94931344T
Other languages
English (en)
Inventor
Hanns A Wendel
Franz-Josef Braun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of ES2177584T3 publication Critical patent/ES2177584T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMULACIONES DE MEDICINA TRANSDERMICA QUE CONTIENEN PROSTAGLANDINA, OPCIONALMENTE UN EXCIPIENTE LIPOFILICO, Y UN ADHESIVO SENSITIVO A LA PRESION DE POLIISOBUTILENO.
ES94931344T 1993-11-19 1994-10-11 Composicion de prostaglandinas transdermica. Expired - Lifetime ES2177584T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/155,126 US5380760A (en) 1993-11-19 1993-11-19 Transdermal prostaglandin composition

Publications (1)

Publication Number Publication Date
ES2177584T3 true ES2177584T3 (es) 2002-12-16

Family

ID=22554196

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94931344T Expired - Lifetime ES2177584T3 (es) 1993-11-19 1994-10-11 Composicion de prostaglandinas transdermica.

Country Status (6)

Country Link
US (2) US5380760A (es)
EP (1) EP0729358B1 (es)
JP (1) JPH09505289A (es)
DE (1) DE69431209T2 (es)
ES (1) ES2177584T3 (es)
WO (1) WO1995013816A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133334A1 (en) * 1993-02-03 1994-08-04 Atsuo Hazato External skin treatment agent composition containing prostacyclins as active ingredient
KR970703137A (ko) * 1994-05-18 1997-07-03 나카토미 히로타카 배뇨장해 치료용 경피투여제제(percutaneously administrable preparation for treating urination disorder)
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6241998B1 (en) 1999-02-02 2001-06-05 Acutek International Dermatological patch
US7083781B2 (en) * 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
US7105571B2 (en) * 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
KR100402334B1 (ko) 2000-06-23 2003-10-22 환인제약 주식회사 알프로스타딜 외용제
US6673841B2 (en) 2001-12-20 2004-01-06 Whan In Pharm. Co., Ltd. Alprostadil alkyl ester-containing composition for external application
US6841574B2 (en) * 2003-01-03 2005-01-11 Nexmed Holdings, Inc. Topical stabilized prostaglandin E compound dosage forms
CA2529852A1 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating hiv
KR20080000647A (ko) * 2005-04-28 2008-01-02 오노 야꾸힝 고교 가부시키가이샤 경피 흡수 제제
ATE539740T1 (de) * 2005-06-10 2012-01-15 3M Innovative Properties Co Verfahren zur handhabung von klebenden laminatabschnitten
JP2008543528A (ja) * 2005-06-27 2008-12-04 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルカートリッジアセンブリ及び適用方法
CA2657435A1 (en) 2006-07-10 2008-07-03 Medipacs, Inc. Super elastic epoxy hydrogel
US9995295B2 (en) 2007-12-03 2018-06-12 Medipacs, Inc. Fluid metering device
US9238102B2 (en) 2009-09-10 2016-01-19 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
RU2633236C2 (ru) 2011-04-07 2017-10-11 Нексмед Холдингс, Инк. Способы и композиции для лечения болезни рейно
US9849270B2 (en) 2011-12-16 2017-12-26 3M Innovative Properties Company Foldable adhesive composite dressing
EP2794793B1 (en) 2011-12-21 2018-11-28 3M Innovative Properties Company Adhesive patch assembly with overlay liner and system and method for making same
US9144671B2 (en) 2011-12-21 2015-09-29 3M Innovative Properties Company Transdermal adhesive patch assembly with removable microneedle array and method of using same
ITRM20120036A1 (it) * 2012-02-02 2013-08-03 Robert Davis Steigerwalt Jr Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare.
US10000605B2 (en) 2012-03-14 2018-06-19 Medipacs, Inc. Smart polymer materials with excess reactive molecules
CN104736192B (zh) 2012-10-10 2018-02-13 3M创新有限公司 用于将微针装置施用至皮肤的施用装置和方法
EP2919849B1 (en) 2012-11-16 2021-01-06 Kindeva Drug Delivery L.P. Force-controlled applicator for applying a microneedle device to skin
NO2753788T3 (es) * 2013-05-10 2018-06-16
KR102274902B1 (ko) 2013-05-31 2021-07-07 쓰리엠 이노베이티브 프로퍼티즈 컴파니 마이크로니들 주사 및 주입 장치 및 그의 사용 방법
US9895520B2 (en) 2013-05-31 2018-02-20 3M Innovative Properties Company Microneedle injection apparatus comprising a dual cover
SG11201509546PA (en) 2013-05-31 2015-12-30 3M Innovative Properties Co Microneedle injection apparatus comprising an inverted actuator
CN107107598B (zh) 2014-12-18 2019-11-22 3M创新有限公司 处理粘合层合物贴剂的方法
WO2017136303A1 (en) 2016-02-05 2017-08-10 3M Innovative Properties Company Transdermal drug delivery systems with fluorosilicone release liners
DE102019120403A1 (de) * 2019-07-29 2021-02-04 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US4103026A (en) * 1976-08-23 1978-07-25 Carlson Lars A Treatment of peripheral vascular disease by non-intraarterial administration of prostaglandin E1
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
JPS56133381A (en) * 1980-03-25 1981-10-19 Nippon Kayaku Co Ltd Pressure-sensitive adhesive tape or sheet containing nitroglycerin
JPS5948409A (ja) * 1982-09-10 1984-03-19 Teikoku Seiyaku Kk 矯正的歯牙移動促進剤
US4515810A (en) * 1983-10-06 1985-05-07 American Cyanamid Company Composition of matter
JPS6185315A (ja) * 1984-10-04 1986-04-30 Teikoku Seiyaku Kk シ−ト状製剤
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method
US4889845A (en) * 1986-06-09 1989-12-26 American Cyanamid Company Vehicle for topical application of pharmaceuticals
JPS63135333A (ja) * 1986-11-26 1988-06-07 Nitto Electric Ind Co Ltd プロスタグランジン類含有貼付剤
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
JPH0676321B2 (ja) * 1987-02-18 1994-09-28 久光製薬株式会社 クロニジン経皮投与製剤
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems
JP2910857B2 (ja) * 1989-04-04 1999-06-23 ニチバン株式会社 プロスタグランジンｅ１経皮吸収製剤
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
JP3568966B2 (ja) * 1992-03-31 2004-09-22 久光製薬株式会社 クロニジン経皮投与製剤

Also Published As

Publication number Publication date
JPH09505289A (ja) 1997-05-27
DE69431209D1 (de) 2002-09-26
US5380760A (en) 1995-01-10
EP0729358A1 (en) 1996-09-04
EP0729358B1 (en) 2002-08-21
DE69431209T2 (de) 2003-04-17
US5480648A (en) 1996-01-02
WO1995013816A1 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
ES2177584T3 (es) Composicion de prostaglandinas transdermica.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2120516T3 (es) Preparacion de composiciones farmaceuticas que contienen una calcitonina.
ES2185711T3 (es) 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos.
MX9201082A (es) Procedimiento para la preparacion de una composicion farmaceutica que comprende gases propelentes libres de cloro.
ES2099056T1 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
BRPI9605663B8 (pt) Bis (resorcinil) triazinas.
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
FI955124L (fi) Protonipumppuinhibiittorin sisältävä eläinlääkeseos
ES267310Y (es) "un dispositivo para aplicar presion compresora a una extremidad de un paciente".
ES2171710T3 (es) Emplastos con hormonas.
EP0426198A3 (en) Ultraviolet photopolymerization of pressure sensitive adhesive formulations
TR199700660T1 (xx) Yeni farnezil transferaz �nleyiciler.
MX9202804A (es) Composicion farmaceutica y terapeutica que comprende una nueva molecula de adhesion intracelular.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
ES2114157T3 (es) Copolimeros de (met)acriloxi-alquil-siloxisilano y alquil(met)acrilatos y su uso como adhesivos sensibles a la presion.
ES2100046T3 (es) Composiciones antipireticas y analgesicas que contienen r-ketorolaco opticamente puro.
DE69224319D1 (de) Photohärtbare Folienklebstoffe
MX9302927A (es) Nuevos peptidos, la preparacion y utilizacion de los mimos.
ES2102598T3 (es) Adhesivos sensibles a la presion.
ES2045484T3 (es) Nuevos derivados de la vitamina d: aplicaciones terapeuticas y a las dosificaciones de los metabolitos de la vitamina d.
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
ES2068350T3 (es) Acidos oxoftalazinilaceticos sustituidos y analogos de los mismos.